Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

BUYER BEWARE!!! ENDV IS INSOLVENT AND DILUTING LIKE CRAZY

1.3 billion fully diluted shares. 317 Million shares currently outstanding, including another 30 million shares gifted to management.

less than $1 million in assets, but the following liabilities:

- $1 million in accounts payable and accrued liabilities
- $4 million in accrued interest owed to the convertible note holders
- $7 million in notes payable of which $6.7 million are past due.

This company is heading to a bankruptcy and asset sale to settle their debts. Management is simply robbing the bank before they head out the door.